Chemotherapy News and Research

Latest Chemotherapy News and Research

Review highlights significant progress in developing new biologic drugs to treat colorectal cancer

New biologic drugs, such as monoclonal antibodies and immunotherapies in clinical development, designed to target metastatic colorectal cancer (CRC) and stimulate the immune system to destroy tumor cells are a significant advance in treatment over conventional chemotherapy.

29 Aug 2017

Targeting bone marrow protein could be effective way to improve stem cell transplants

Bone marrow contains hematopoetic stem cells, the precursors to every blood cell type. These cells spring into action following bone marrow transplants, bone marrow injury and during systemic infection, creating new blood cells, including immune cells, in a process known as hematopoiesis.

28 Aug 2017

Study tests therapeutic effect of conventional and new cancer drug combinations

Cancer is one of the major causes of death worldwide affecting 8.2 million of people per year, and in the US, the number of new cases will achieve 1.6 million in 2017. The global impact of this disease costs a trillion of dollars, which makes critical the development of new drugs and treatment against it.

28 Aug 2017

Simultaneous treatment with anti-PD1 and anti-OX40 cancer therapies may have detrimental effect

Concurrent administration of the T-cell stimulating anti-OX40 antibody and the immune checkpoint inhibitor anti-PD1 antibody attenuated the effect of anti-OX40 and resulted in poor treatment outcomes in mice.

28 Aug 2017

Research paves way for new drugs that may prevent tumor repopulation after radiation therapy

Whenever an organism is damaged, the cells surrounding the wound receive signals to proliferate more intensely so as to regenerate the injured tissue.

26 Aug 2017

Scientists develop new chimeric antibody to treat malignant cancers in dogs

Scientists have developed a new chimeric antibody that suppresses malignant cancers in dogs, showing promise for safe and effective treatment of intractable cancers.

26 Aug 2017

Cancer treatments could affect person’s sense of taste and dietary preferences

Cancer treatments have many effects on patients – some apparent and some less so. One of the most noticeable changes is a change in taste.

26 Aug 2017

Tumor irradiation may prolong survival of NSCLC patients undergoing novel chemotherapy formulation

Patients with unresectable, or inoperable, lung cancer are often given a dismal prognosis, with low rates of survival beyond a few years.

26 Aug 2017

Purdue startup wins SAH Assistive Technology Grant to improve veterans’ ability to live independently

Prehensile Technologies, a company developing robotic assistive technology devices, is developing RoboTable, a robotic over-the-bed table, to help veterans and others with disabilities or mobility impairments better use their laptop computers and mobile devices while restricted to bed, allowing them to be more independent and remain productive with work or school.

26 Aug 2017

New approach delivers drugs to cancer cells while protecting healthy tissues

Cancer treatments, including chemotherapy, have helped many people with the disease to go on to live healthy lives.

26 Aug 2017

Study may lead to new therapy options for treatment resistant, relapsed endometrial cancer

A team of Cleveland Clinic researchers have discovered a key pathway that leads to recurrence and treatment resistance in endometrial cancer, providing the potential for much needed new therapies for women with limited options.

24 Aug 2017

New imaging technique reveals oxygen levels in prostate tumors

A new imaging technique uncovers oxygen levels in prostate tumors and could lead to a non-invasive way to determine which tumors are more difficult to treat, according to a Cancer Research UK-funded study published in Theranostics.

24 Aug 2017

‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost

When doctors talk about a new leukemia drug from Novartis, they ooze enthusiasm, using words like "breakthrough," "revolutionary" and "a watershed moment."

23 Aug 2017

Female patients with esophageal cancer have superior response to treatment, study reveals

Female patients with locally advanced esophageal cancer that is treated with chemotherapy and radiation therapy before surgery are more likely to have a favorable response to the treatment than male patients are, and women are less likely to experience cancer recurrence, according to a study published online today in The Annals of Thoracic Surgery.

22 Aug 2017

Plant virus-based system can be used to deliver anti-cancer drugs

An article published in Experimental Biology and Medicine (Volume 242, Issue 14, August 2017) reports that a plant virus-based system can be used to deliver anti-cancer drugs.

21 Aug 2017

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

The U.S. Food and Drug Administration (FDA) today approved Besponsa (inotuzumab ozogamicin) in the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) - a rare form of ALL.

17 Aug 2017

$FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL$

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

17 Aug 2017

Sanford Health launches solid tumor oncolytic virus clinical trial

Sanford Health is the first site in the United States to launch a clinical trial using a genetically-engineered virus that aims to destroy therapy-resistant tumors.

17 Aug 2017

Researchers discover synthetic compound effective at relieving neuropathic pain

A team of scientists led by chemists Stephen Martin and James Sahn at The University of Texas at Austin have discovered what they say is a powerful pain reliever that acts on a previously unknown pain pathway.

17 Aug 2017

Immunotherapy drug shows favorable safety profile in patients with advanced small cell lung cancer

The immunotherapy drug pembrolizumab has demonstrated a favorable safety profile and "promising durable clinical activity" in pretreated patients who exhibit high levels of the PD-L1 protein in advanced stages of small cell lung cancer (SCLC) – an aggressive form of the disease

16 Aug 2017

Chemotherapy News and Research

Latest Chemotherapy News and Research

Review highlights significant progress in developing new biologic drugs to treat colorectal cancer

Targeting bone marrow protein could be effective way to improve stem cell transplants

Study tests therapeutic effect of conventional and new cancer drug combinations

Simultaneous treatment with anti-PD1 and anti-OX40 cancer therapies may have detrimental effect

Research paves way for new drugs that may prevent tumor repopulation after radiation therapy

Scientists develop new chimeric antibody to treat malignant cancers in dogs

Cancer treatments could affect person’s sense of taste and dietary preferences

Tumor irradiation may prolong survival of NSCLC patients undergoing novel chemotherapy formulation

Purdue startup wins SAH Assistive Technology Grant to improve veterans’ ability to live independently

New approach delivers drugs to cancer cells while protecting healthy tissues

Study may lead to new therapy options for treatment resistant, relapsed endometrial cancer

New imaging technique reveals oxygen levels in prostate tumors

‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost

Female patients with esophageal cancer have superior response to treatment, study reveals

Plant virus-based system can be used to deliver anti-cancer drugs

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

Sanford Health launches solid tumor oncolytic virus clinical trial

Researchers discover synthetic compound effective at relieving neuropathic pain

Immunotherapy drug shows favorable safety profile in patients with advanced small cell lung cancer

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in